Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
APstem Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
APstem Therapeutics

APstem Therapeutics

Seed

APstem Therapeutics: Advancing stem cell discoveries to combat diseases and aging challenges.

HQ
Fremont, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

APstem Therapeutics was founded with the mission to eradicate difficult-to-heal diseases and address the challenges associated with aging. The company has pioneered the discovery of Adult High-Plasticity Stem Cells (AHPSCs™), which hold significant potential in regenerative medicine. APstem Therapeutics focuses on developing innovative stem cell therapies aimed at treating a variety of complex medical conditions, thereby improving patient outcomes and quality of life.

Notable affiliated individuals and investors include leading experts in stem cell research and biotechnology. APstem Therapeutics has achieved key milestones in preclinical studies, demonstrating the efficacy and safety of their AHPSCs™. The company's advancements have positioned it as a frontrunner in the field of regenerative medicine, making a substantial impact on the future of healthcare by offering promising new treatments for previously intractable diseases.

APstem Therapeutics - Similar Companies

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

AgeX Therapeutics logo

AgeX Therapeutics

Aspen Neuroscience logo

Aspen Neuroscience

Cellebration Life Sciences logo

Cellebration Life Sciences

Stemcyte logo

Stemcyte

stemcyte.com

Ankasa Regenerative Therapeutics logo

Ankasa Regenerative Therapeutics

Altos Labs logo

Altos Labs

altoslabs.com

Celltex Therapeutics logo

Celltex Therapeutics

celltexbank.com

Animal Cell Therapies logo

Animal Cell Therapies

Apic Bio logo

Apic Bio

AVM Biotechnology logo

AVM Biotechnology

avmbiotech.com

Forever Labs logo

Forever Labs

foreverlabs.com

Apie Therapeutics logo

Apie Therapeutics

Deciduous Therapeutics logo

Deciduous Therapeutics

deciduoustx.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

APstem Therapeutics - Quick Facts

Who are APstem Therapeutics' competitors?

Companies similar to APstem Therapeutics include Stemson Therapeutics, AgeX Therapeutics, Aspen Neuroscience and Cellebration Life Sciences.

When was APstem Therapeutics founded?

APstem Therapeutics was founded in 2017.

Where is APstem Therapeutics' headquarters located?

APstem Therapeutics' headquarters is located in Fremont, CA, US.

When was APstem Therapeutics' last funding round?

APstem Therapeutics' most recent funding round was for $2.8M (USD) in September 2020.

How much has APstem Therapeutics raised to-date?

As of Sep 1, 2020, APstem Therapeutics has raised a total of $4.3M (USD).

How many employees does APstem Therapeutics have?

APstem Therapeutics has 6 employees as of Feb 4, 2024.

APstem Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Stem Cell Therapies
Tags
  • Biotech
  • Healthcare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified